If Nvidia Can’t Dodge Antitrust Review, What Happens to My Own Acquisition?

My Exit Isn’t a Wire Transfer

I picture my exit as a wire transfer: buyer signs, buyer pays, I’m done. That picture skips the part where regulators get a say first, and deals do fall apart in that gap.

On September 3, 2026, Nvidia announced it would acquire Hugging Face, the open-source AI model repository used by more than 18 million developers, for $12.93 billion in cash and equity. Nvidia’s earlier AI deals with Groq and Poolside were structured as licensing and hiring arrangements, quasi-mergers that let Nvidia sidestep mandatory antitrust filing. At $12.93 billion for the industry’s dominant open-model hosting platform, this one can’t be dressed up the same way. TechCrunch reported it triggers full Hart-Scott-Rodino (HSR) review in the US plus a separate EU merger review, and it isn’t expected to close until the first half of 2027, a multi-month gap between an accepted agreement and an actual closing.

How Antitrust Review Actually Works

What HSR Review Actually Requires

The Hart-Scott-Rodino Act (the federal law requiring big deals to clear antitrust review before closing) forces buyers and sellers above a size threshold to file with the FTC and DOJ and wait before closing. Nvidia and Hugging Face are well above that threshold, so this deal gets the full review, not a quiet close. Regulators can request more information and extend the wait for months.

Why the Signing-to-Closing Gap Is Where Deals Actually Die

Signing and closing are two different events, and the space between them is where deals actually die. Between them, financing can wobble and the buyer’s priorities can shift. A “material adverse change” clause can let a buyer walk if my business changes during the wait, and a reverse termination fee is what I negotiate to get paid if the buyer walks over regulatory risk instead. The longer that gap runs, the more time key employees and customers have to lose confidence.

What This Means for My Own Exit Planning

Most founders assume regulatory review is a big-company problem. Nvidia already faces antitrust inquiries over GPU supply, and regulators reviewing a dominant buyer look harder at what a deal adds to that dominance. If my acquirer has market power, I should expect my deal to inherit some of that scrutiny, even if my company looks unremarkable.

Picture a startup being acquired by a strategic buyer that already controls a large share of the same market. The deal itself might clear review easily, but the buyer’s own footprint can trigger a second request and push the timeline out by months, and that delay alone can cost the seller leverage even when nothing about the seller’s own business raised a flag.

Where Founders Get This Wrong

Assuming Signing Day Is Closing Day. Founders celebrate a signed agreement as the end of the process. The real risk sits in the months of review that follow, where the deal can still unravel.

Not Negotiating for Regulatory Delay Risk. Founders leave reverse termination fees and outside closing dates off the table, treating them as a fight over an unlikely scenario. No fee means no payout if the buyer walks over regulatory risk. No outside date means the deal can drift indefinitely.

Ignoring the Acquirer’s Own Regulatory Baggage. Founders vet a buyer’s cash and reputation but skip whether it’s already under scrutiny elsewhere. A buyer’s existing antitrust exposure becomes my exposure the moment I sign.

10-Minute Self-Check

Before I sign a letter of intent with a strategic acquirer, I work through this:

Do I know whether this deal size clears the current HSR filing threshold?

Have I asked how dominant this buyer already is in my market?

Does my agreement include a reverse termination fee tied to regulatory failure?

Is there an outside date forcing a decision instead of an open-ended wait?

Have I modeled what my business needs to survive a multi-month closing gap?

Does my team know the deal isn’t final at signing?

If I can’t answer yes to most of these, my deal isn’t ready for the regulatory clock ahead.

Signing Isn’t Closing

A signed deal and a closed deal are not the same event. Founders who plan for that gap protect their leverage. The ones who treat signing as the finish line learn the hard way how long “almost done” can last.

Curious What Legal Blind Spots Could Delay Your Own Eventual Exit?

Join our upcoming Product Launch Master Class on September 29th, 2026. You will learn how to identify legal risks before launch, understand which agreements and policies your business may need, and prepare your company for customers, investors, and future growth.

If Nvidia Can’t Dodge Antitrust Review, What Happens to My Own Acquisition?